Suppression of serum immunoreactive human epidermal growth factor by acute increase in prolactin in women.
Epidermal growth factor (EGF) is known to stimulate proliferation of various mammalian cells and secretion of prolactin (PRL) from rat anterior pituitary tumor cells. The effect of an acute increase in serum PRL induced by thyrotropin releasing hormone (TRH) or metoclopramide (MCP) on the serum immunoreactive EGF concentration was examined in nine hyperprolactinemic patients and eight normoprolactinemic women. The basal level of serum EGF in normoprolactinemic subjects was 472.8 +/- 51.1 pg/ml (Mean +/- SEM), which was not significantly different from that in hyperprolactinemic patients (487.8 +/- 22.5 pg/ml). The serum EGF concentration was decreased to 40-50% of the basal level after the abrupt increase in serum PRL induced by the injection of TRH or MCP in normoprolactinemic subjects, but no significant change in serum EGF occurred in hyperprolactinemic patients after MCP injection, in spite of a significant increase in PRL. These results suggest that an acute increase of serum PRL in normoprolactinemic women, but not in hyperprolactinemic patients, suppresses serum EGF.
Chen
C F
CF
Department of Obstetrics and Gynecology, Osaka University Medical School, Japan.
Kurachi
H
H
Miyake
A
A
Aono
T
T
Tanizawa
O
O
D000236:Adenoma / Q000097:blood; D000293:Adolescent; D000328:Adult; D004815:Epidermal Growth Factor / Q000097:blood*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood*; D008787:Metoclopramide / Q000494:pharmacology; D010906:Pituitary Hormone-Releasing Hormones / Q000494:pharmacology; D010911:Pituitary Neoplasms / Q000097:blood; D011863:Radioimmunoassay; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D010906:Pituitary Hormone-Releasing Hormones; D013973:Thyrotropin-Releasing Hormone; D004815:Epidermal Growth Factor; D008787:Metoclopramide